These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16314499)

  • 1. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
    Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
    Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
    Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
    J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
    Luo DD; Phillips A; Fraser D
    Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
    Stroschein SL; Bonni S; Wrana JL; Luo K
    Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
    Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
    Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
    Stroschein SL; Wang W; Zhou S; Zhou Q; Luo K
    Science; 1999 Oct; 286(5440):771-4. PubMed ID: 10531062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
    Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
    Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
    Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
    Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.
    Schiro MM; Stauber SE; Peterson TL; Krueger C; Darnell SJ; Satyshur KA; Drinkwater NR; Newton MA; Hoffmann FM
    PLoS One; 2011; 6(9):e25021. PubMed ID: 21949838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
    Qureshi HY; Ricci G; Zafarullah M
    Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.